kitio.aiUnlearn vs DrugCard
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. Unlearn starts at See pricing page and DrugCard starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Participant digital twins
- Trial design simulation
- Interim analysis support
- Digital twin comparators
- Regulatory strategy expertise
- Automated literature screening
- Regulatory intelligence
- PSUR and PBRER automation
- Adverse event database
- Pharmacovigilance services
| Feature | Unlearn | DrugCard |
|---|---|---|
| Best for | Digital twins of trial participants for clinical development | AI literature screening and pharmacovigilance for drug makers |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Unlearn | DrugCard |
| Based in | – | – |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
Unlearn starts at See pricing page and DrugCard starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Oct 29, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
Unlearn
- Targets specific decisions across the trial lifecycle
- Can support smaller study designs
- Works for randomized and single-arm studies
- Enterprise service, no self-serve sign-up
- No published pricing
- Aimed only at clinical development teams
DrugCard
- Covers local journals as well as global ones
- Software plus expert services
- Supports audit readiness
- No public pricing
- Specialist audience only
- Some site content only in Ukrainian
Which one should you choose?
Choose Unlearn if you want:
- Targets specific decisions across the trial lifecycle
- Can support smaller study designs
- Works for randomized and single-arm studies
Watch out: enterprise service, no self-serve sign-up.
Choose DrugCard if you want:
- Covers local journals as well as global ones
- Software plus expert services
- Supports audit readiness
Watch out: no public pricing.
Unlearn vs DrugCard FAQ
What is the difference between Unlearn and DrugCard?
Unlearn: Digital twins of trial participants for clinical development. DrugCard: AI literature screening and pharmacovigilance for drug makers. Both are legal, finance & hr tools.
Is Unlearn or DrugCard cheaper?
Unlearn starts at See pricing page and DrugCard starts at See pricing page. Check both pricing pages for current plans.
Do Unlearn and DrugCard have free plans?
Unlearn: No. DrugCard: No.
Who makes Unlearn?
Unlearn is made by Unlearn.
Who makes DrugCard?
DrugCard is made by DrugCard.
Which should I choose, Unlearn or DrugCard?
Choose Unlearn if you value targets specific decisions across the trial lifecycle and can support smaller study designs. Choose DrugCard if you value covers local journals as well as global ones and software plus expert services.